Heron Therapeutics Inc (HRTX)
2.855
+0.08
(+3.07%)
USD |
NASDAQ |
Jul 05, 16:00
2.855
0.00 (0.00%)
After-Hours: 16:09
Heron Therapeutics SG&A Expense (Annual): 116.66M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 116.66M |
| December 31, 2022 | 119.95M |
| December 31, 2021 | 127.33M |
| December 31, 2020 | 106.08M |
| December 31, 2019 | 127.66M |
| December 31, 2018 | 93.87M |
| December 31, 2017 | 82.16M |
| December 31, 2016 | 69.03M |
| December 31, 2015 | 35.74M |
| December 31, 2014 | 19.73M |
| December 31, 2013 | 21.94M |
| December 31, 2012 | 8.657M |
| December 31, 2011 | 3.501M |
| December 31, 2010 | 3.971M |
| December 31, 2009 | 3.707M |
| December 31, 2008 | 4.307M |
| December 31, 2007 | 4.681M |
| December 31, 2006 | 3.628M |
| December 31, 2005 | 3.565M |
| Date | Value |
|---|---|
| December 31, 2004 | 3.225M |
| December 31, 2003 | 2.80M |
| December 31, 2002 | 3.024M |
| December 31, 2001 | 3.247M |
| December 31, 2000 | 3.463M |
| December 31, 1999 | 3.40M |
| December 31, 1998 | 2.50M |
| December 31, 1997 | 7.40M |
| December 31, 1996 | 16.40M |
| December 31, 1995 | 9.60M |
| December 31, 1994 | 8.50M |
| December 31, 1993 | 17.50M |
| December 31, 1992 | 8.80M |
| December 31, 1991 | 4.90M |
| December 31, 1990 | 5.10M |
| December 31, 1989 | 6.70M |
| December 31, 1988 | 6.90M |
| December 31, 1987 | 4.50M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
106.08M
Minimum
2020
127.66M
Maximum
2019
119.54M
Average
119.95M
Median
2022
SG&A Expense (Annual) Benchmarks
| Arcutis Biotherapeutics Inc | 185.14M |
| Marinus Pharmaceuticals Inc | 61.15M |
| Amgen Inc | 6.179B |
| Ionis Pharmaceuticals Inc | 232.60M |
| Ligand Pharmaceuticals Inc | 52.79M |